Search results
Morning Brew: NIO Reports Revenue Decline, Novavax Gains on FDA
Guru Focus· 2 days agoS&P futures vs fair value: +2.00. Nasdaq futures vs fair value: +28.00. The S&P 500 futures are up...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via AOL· 5 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 5 days agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
KIMT Mason City· 15 hours agoThe JN.1 version of the virus, along with its descendants KP.2 and KP.3 are the most common strain...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 3 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
FDA advisers back updating COVID shots to target JN.1 virus family
BioPharma Dive via Yahoo Finance· 2 days agoThe unanimous recommendation from the panel should help Novavax, which would have had difficulty...
Peapack Gladstone Financial Corp Has $538,000 Stock Position in WEC Energy Group, Inc. (NYSE:WEC)
ETF DAILY NEWS· 1 day agoPeapack Gladstone Financial Corp lessened its stake in WEC Energy Group, Inc. (NYSE:WEC – Free Report) by 4.4% in the 4th quarter, according to its most recent disclosure with the Securities ...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 3 days agoThe 16 advisors did not vote on whether to favor the original JN.1 variant or one of its successors...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Colorado Springs Gazette· 5 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...